BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  BD to Announce Financial Results for its First Quarter of Fiscal 2024

  BD, a leading global medical technology company, announced that it will report financial results for its first quarter of fiscal year 2024 on Thursday, February 1, 2024.

  January 4, 2024

   · 

  2 min read
• Biotech Bay

  Nevro to Present at 42nd Annual J.P. Morgan Healthcare Conference

  Nevro Corp. announced that members of its management team will participate in the 42nd Annual J.P. Morgan Healthcare Conference on Thursday, January 11, 2024.

  January 4, 2024

   · 

  2 min read
• Genetown

  Stoke Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

  Stoke Therapeutics, Inc. announced that management will present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 6:45 p.m. ET.

  January 4, 2024

   · 

  1 min read
• BioMidwest

  Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock

  Catalyst Pharmaceuticals, Inc. announced that it has commenced an underwritten public offering of $150,000,000 of its common stock.

  January 4, 2024

   · 

  4 min read
• Telix Announces Planned Registered Public Offering and Listing in the United States

  Telix Pharmaceuticals Limited announces that it is considering an initial public offering of American Depositary Shares representing its ordinary shares in the United States and listing on the Nasdaq Global Market.

  January 4, 2024

   · 

  4 min read
• Business

  Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues

  Pacira BioSciences, Inc. reported preliminary unaudited total revenue of $675.0 million for the year ended December 31, 2023, compared with $666.8 million for the year ended December 31, 2022.

  January 4, 2024

   · 

  13 min read
• BioMidwest

  Benson Hill Announces Gains in Soybean Breeding Program; Introduces Five 2024 Soybean Varieties Delivering Higher Protein and Improved Yield Potential

  Benson Hill, Inc., an ag tech company unlocking the natural genetic diversity of plants, announced that recent advances in its soybean breeding program will drive the doubling of its seed portfolio by 2025.

  January 4, 2024

   · 

  9 min read
• Business

  INOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI™ (toripalimab-tpzi)

  INOVIO today announced a clinical collaboration and supply agreement with Coherus BioSciences, Inc. (Coherus, NASDAQ: CHRS) to evaluate the combination of INO-3112 and LOQTORZI.

  January 4, 2024

   · 

  10 min read
• Drug Development

  Rigel Announces Collaboration with CONNECT to Conduct a Phase 2 Trial of Olutasidenib in Glioma

  Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced a collaboration with CONNECT, an international collaborative network of pediatric cancer centers, to conduct a Phase 2 clinical trial to evaluate REZLIDHIA.

  January 4, 2024

   · 

  10 min read
• Deals

  Elevance Health to Acquire Paragon Healthcare

  Elevance Health announced that it has entered into an agreement to acquire Paragon Healthcare, Inc., a company specializing in life-saving and life-giving infusible and injectable therapies.

  January 4, 2024

   · 

  7 min read